Navigation Links
Golub Capital Provides Financing to Support The Recapitalization of Integrated DNA Technologies, Inc.

NEW YORK, April 23 /PRNewswire/ -- Golub Capital today announced that it has provided $12.0 million of senior subordinated debt to support the recapitalization and ongoing growth of Integrated DNA Technologies, Inc. ("IDT").  This transaction marks the first investment made by GC 2009 Mezzanine Partners, L.P., which is Golub Capital's sixth fund dedicated to middle market mezzanine debt financings.  The fund targets attractive net returns by investing primarily in mezzanine and second lien debt investments in U.S. middle market companies.

Headquartered in Coralville, Iowa, IDT is the leading supplier of custom nucleic acids in the United States, serving academic, government, and commercial researchers in biotechnology, clinical diagnostics, and pharmaceutical development. IDT's primary business is the manufacture of custom, synthetic DNA and RNA oligonucleotides and genes. Today, IDT synthesizes and ships an average of 36,000 custom oligos per day to more than 86,000 customers worldwide. IDT's manufacturing locations include facilities in Coralville, Iowa; San Diego, California; and Leuven, Belgium.

"We are excited to have the opportunity to partner with the IDT management team and to begin a lending relationship with the Company," commented Senior Managing Director Andrew Steuerman. "IDT has built its market leading position over the last 25 years by delivering exceptional product quality and building longstanding customer relationships."

"This is our first time working with Golub Capital," noted Dr. Joseph Walder, IDT's founder and CEO.  "The financing provided by Golub Capital will help ensure that IDT maintains a strong balance sheet and has the flexibility necessary to pursue our ambitious plans for the future."

About Golub Capital

With $4 billion in capital, Golub Capital is a leading provider of financing solutions for the middle market, including one-loan financings (through the firm's proprietary GOLD facility), senior, second lien and subordinated debt, preferred stock and co-investment equity. The firm also underwrites and syndicates senior credit facilities up to $200 million. Golub Capital's hold sizes range from $10 million to $75 million per transaction.  Golub Capital was ranked by Thomson Reuters Loan Pricing Corporation as the #1 Traditional Middle Market Bookrunner for 2009.  For two years in a row, Golub Capital was named "Middle Market Lender of the Year" by Buyouts Magazine for achievements in 2009 and 2008.  Other honors awarded to Golub Capital include being named "2009 Mezzanine Financing Agent of the Year" and "2008 Financing Firm of the Year" by M&A Advisor and "2008 M&A Lender of the Year" by ACG's Mergers & Acquisitions. Golub Capital is a national firm with offices in Chicago, New York and Atlanta. For more information, please visit the firm's website at

Golub Capital Incorporated (and its various affiliates) creates and manages multiple private funds.  One of its affiliates, GC Advisors LLC is an investment advisor registered with the United States Securities and Exchange Commission. 

SOURCE Golub Capital
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Golub Capital Provides Debt Financing to Support the Acquisition of DNA Diagnostics Center, Inc. by MTS Health Investors, LLC
2. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
3. AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol APPY
4. XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market
5. AspenBio Pharma to Present at the Roth Capital Partners New York Investor Conference
6. Tutogen Medical, Inc. to Present at the Roth Capital Partners 2007 New York Conference
7. Osteotech to Present at Roth Capital Partners 2007 New York Investor Conference
8. CryoLife to Present at Bear Stearns Healthcare and First Albany Capitals Regenerative Technologies Conferences in New York
9. Luminex Corporation to Present at Americas Growth Capital Emerging Growth Conference
10. Altheus Therapeutics Secures $3.6 Million in Venture Capital
11. XTL to Appeal NASDAQ Staff Determination; XTL May Transfer its ADR Listing to the NASDAQ Capital Market
Post Your Comments:
(Date:11/30/2015)... 2015 /PRNewswire/ - Zenith Epigenetics Corp. ("Zenith" or the "Company") ... Wong to its Board of Directors to replace Dr. ... a wealth of experience as co-founder of Resverlogix, with expertise ... --> --> Dr. Wong remarked, "I ... directors. Zenith,s long standing expertise in epigenetics and the advanced ...
(Date:11/30/2015)... 30, 2015 Human Longevity, Inc. (HLI), the ... acquired Cypher Genomics, Inc., a leading genome informatics company ... software solutions. The San Diego -based ... Cypher CEO and Co-founder, Ashley Van Zeeland , Ph.D., ...  Financial details of the deal were not disclosed. ...
(Date:11/30/2015)... Ill. , Nov. 30, 2015  AbbVie, is ... program that focuses on a daily routine for managing ... take their medication can affect the way the body ... follow to their a daily routine are important. The ... to help patients better manage their hypothyroidism by establishing ...
(Date:11/30/2015)... and PETACH TIKVAH, Israel , Nov. 30, ... BCLI ), a leading developer of adult stem cell technologies ... Cell Therapeutics Ltd., has been awarded an additional grant of ... the Chief Scientist (OCS). This grant, the second this year, ... activities to approximately $1.8 million (approximately NIS7 million).  ...
Breaking Biology Technology:
(Date:11/9/2015)... JOSE, Calif. , Nov. 9, 2015  Synaptics ... human interface solutions, today announced broader entry into the ... vehicle-specific solutions that match the pace of consumer electronics ... and biometric sensors are ideal for the automotive industry ... vehicle. Europe , ...
(Date:10/29/2015)... 2015   MedNet Solutions , an innovative SaaS-based ... clinical research, is pleased to announce that it has ... as one of only three finalists for a ... and Growing" category. The Tekne Awards honor Minnesota ... technology innovation and leadership. iMedNet™ eClinical ...
(Date:10/29/2015)... , Oct. 29, 2015  Rubicon Genomics, ... for U.S. distribution of its DNA library preparation ... and Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq ... the preparation of NGS libraries for liquid biopsies--the ... diagnostic and prognostic applications in cancer and other ...
Breaking Biology News(10 mins):